> There are many very cheap ways of keeping physicians up-to date, such as a conference presentation of the drug, followed by a Q&A session, with a recording fr

> There are many very cheap ways of keeping physicians up-to date, such as a conference presentation of the drug, followed by a Q&A session, with a recording freely available online. 5 minutes of face time with a busy physician and supplying them with a useful article targeted to their specific needs can be far more effective. > Which are covered in the already mentioned 20% that goes to R&D (source pending). Are you purposefully ignoring information you dislike? The dev part was an honest error while I was editing, and I don't think the accusation is called for. Regulatory costs, and I think of quality also being in that group, is not an R&D cost and is substantial.